Federico, P.; Petrillo, A.; Giordano, P.; Bosso, D.; Fabbrocini, A.; Ottaviano, M.; Rosanova, M.; Silvestri, A.; Tufo, A.; Cozzolino, A.;
et al. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives. Cancers 2020, 12, 3025.
https://doi.org/10.3390/cancers12103025
AMA Style
Federico P, Petrillo A, Giordano P, Bosso D, Fabbrocini A, Ottaviano M, Rosanova M, Silvestri A, Tufo A, Cozzolino A,
et al. Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives. Cancers. 2020; 12(10):3025.
https://doi.org/10.3390/cancers12103025
Chicago/Turabian Style
Federico, Piera, Angelica Petrillo, Pasqualina Giordano, Davide Bosso, Antonietta Fabbrocini, Margaret Ottaviano, Mario Rosanova, Antonia Silvestri, Andrea Tufo, Antonio Cozzolino,
and et al. 2020. "Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives" Cancers 12, no. 10: 3025.
https://doi.org/10.3390/cancers12103025
APA Style
Federico, P., Petrillo, A., Giordano, P., Bosso, D., Fabbrocini, A., Ottaviano, M., Rosanova, M., Silvestri, A., Tufo, A., Cozzolino, A., & Daniele, B.
(2020). Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Status and Novel Perspectives. Cancers, 12(10), 3025.
https://doi.org/10.3390/cancers12103025